HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sanzio Candeletti Selected Research

Opioid Analgesics (Opioids)

11/2022Effects of Different Opioid Drugs on Oxidative Status and Proteasome Activity in SH-SY5Y Cells.
1/2022Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation.
1/2020Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists.
2/2019Tapentadol: an analgesic that differs from classic opioids due to its noradrenergic mechanism of action.
8/2015A new potent analgesic agent with reduced liability to produce morphine tolerance.
5/2015Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N/OFQ-NOPr and PDYN/KOPr systems in rats: Relevance to sporadic Parkinson's disease.
5/2013Different alcohol exposures induce selective alterations on the expression of dynorphin and nociceptin systems related genes in rat brain.
2/2013Ethanol induces epigenetic modulation of prodynorphin and pronociceptin gene expression in the rat amygdala complex.
3/2011Ethanol and acetaldehyde exposure induces specific epigenetic modifications in the prodynorphin gene promoter in a human neuroblastoma cell line.
3/2009Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sanzio Candeletti Research Topics

Disease

11Pain (Aches)
11/2022 - 10/2006
10Neuroblastoma
01/2018 - 06/2008
6Neuralgia (Stump Neuralgia)
11/2022 - 04/2017
5Chronic Pain
01/2022 - 10/2006
5Parkinson Disease (Parkinson's Disease)
11/2015 - 10/2005
3Hyperalgesia
11/2022 - 12/2020
3Alcoholism (Alcohol Abuse)
01/2017 - 02/2013
3Seizures (Absence Seizure)
06/2008 - 11/2002
2Cancer Pain
01/2022 - 04/2017
2Alzheimer Disease (Alzheimer's Disease)
05/2016 - 09/2015
2Parkinsonian Disorders (Parkinsonism)
08/2010 - 10/2005
1Burns
01/2024
1Brain Neoplasms (Brain Tumor)
01/2024
1Xeroderma Pigmentosum (Kaposi's Disease)
01/2024
1Inflammation (Inflammations)
01/2024
1Drug-Related Side Effects and Adverse Reactions
11/2022
1Respiratory Insufficiency (Respiratory Failure)
01/2022
1Opioid-Related Disorders (Opiate Addiction)
01/2022
1Neoplasms (Cancer)
01/2022
1Painful Neuropathy
11/2021
1Fabry Disease (Fabry's Disease)
10/2021
1Hypersensitivity (Allergy)
02/2021
1Colorectal Neoplasms (Colorectal Cancer)
12/2020
1Opioid-Induced Constipation
01/2020
1Chronic Renal Insufficiency
01/2020
1Chronic Kidney Failure (Chronic Renal Failure)
01/2020
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
12/2019
1Acute Pain
02/2019
1Serotonin Syndrome (Syndrome, Serotonin)
02/2019
1Nociceptive Pain
02/2019
1Rheumatoid Arthritis
04/2017
1Osteoarthritis
04/2017
1Low Back Pain (Lumbago)
04/2017
1Body Weight (Weight, Body)
12/2016
1Substance-Related Disorders (Drug Abuse)
04/2016

Drug/Important Bio-Agent (IBA)

12Opioid Analgesics (Opioids)IBA
11/2022 - 10/2005
12NociceptinIBA
01/2018 - 11/2002
6Analgesics (Analgesic Drugs)IBA
11/2022 - 08/2015
5NeuropeptidesIBA
08/2019 - 11/2002
5Morphine (MS Contin)FDA LinkGeneric
03/2019 - 10/2006
4Proteasome Endopeptidase Complex (Proteasome)IBA
11/2022 - 11/2015
4Fentanyl (Sublimaze)FDA LinkGeneric
01/2020 - 10/2013
4Opioid Receptors (Opioid Receptor)IBA
01/2018 - 08/2014
3EnzymesIBA
01/2024 - 10/2021
3Proteins (Proteins, Gene)FDA Link
01/2024 - 09/2015
3Messenger RNA (mRNA)IBA
10/2021 - 11/2002
3Ethanol (Ethyl Alcohol)IBA
02/2021 - 03/2011
3preproenkephalinIBA
12/2020 - 03/2011
3TapentadolFDA Link
01/2020 - 08/2014
3Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2016 - 06/2012
3Nociceptin ReceptorIBA
08/2010 - 11/2002
3Kainic Acid (Kainate)IBA
06/2008 - 11/2002
2SmokeIBA
01/2024 - 01/2022
2NicotineFDA Link
01/2024 - 12/2019
2MT2 Melatonin ReceptorIBA
11/2022 - 10/2020
2MelatoninIBA
11/2022 - 10/2020
2Buprenorphine (Subutex)FDA LinkGeneric
01/2022 - 01/2020
2Proteasome InhibitorsIBA
12/2020 - 03/2019
2Neurotransmitter Agents (Neurotransmitter)IBA
10/2020 - 08/2019
2AcetaldehydeIBA
01/2017 - 03/2011
2Sirtuin 1IBA
05/2016 - 09/2015
2ManebIBA
11/2015 - 05/2015
2ParaquatIBA
11/2015 - 05/2015
1AntioxidantsIBA
01/2024
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2024
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2024
1Cytochrome P-450 CYP2B6 (CYP2B6)IBA
01/2024
18-hydroxyguanosineIBA
01/2024
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
01/2024
1DNA Glycosylases (DNA Glycosylase)IBA
01/2024
18-hydroxyguanineIBA
01/2024
1AldehydesIBA
01/2024
1metariboadenosine triphosphorousIBA
01/2024
1delta Opioid Receptors (delta Opioid Receptor)IBA
11/2022
1N- (2- ((3- bromophenyl)- (4- fluorophenyl)amino)ethyl)acetamideIBA
11/2022
1mu Opioid Receptors (mu Opioid Receptor)IBA
11/2022
1AerosolsIBA
01/2022
16'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA
01/2022
1CytokinesIBA
11/2021
1GlycosphingolipidsIBA
10/2021
1GalactosidasesIBA
10/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2020
1UbiquitinIBA
12/2020
1Antineoplastic Agents (Antineoplastics)IBA
12/2020
1ONX 0912IBA
12/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2020
1Narcotic Antagonists (Opioid Antagonists)IBA
01/2020
1Heroin (Diamorphine)IBA
03/2019
1Hormones (Hormone)IBA
02/2019
1Serotonin (5 Hydroxytryptamine)IBA
02/2019
1N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
12/2016
1Peptides (Polypeptides)IBA
05/2016
1Amyloid (Amyloid Fibrils)IBA
05/2016
1Cocaine (Cocaine HCl)IBA
04/2016
1ATP dependent 26S protease (26S proteasome)IBA
04/2016

Therapy/Procedure

5Therapeutics
01/2022 - 10/2005
1Renal Dialysis (Hemodialysis)
01/2020
1Transjugular Intrahepatic Portasystemic Shunt
01/2020
1Self Administration (Administration, Self)
03/2019
1Analgesia
03/2019